Tumour model

RBL-1

Leukemia
SyngeneicIn vitro

Model characteristics

Organism
Rat
Tissue of origin
Peripheral blood
Pathology
Leukemia
Model type
In vitro, Syngeneic
Availability
2 to 3 weeks

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Human
Peripheral blood
Chronic myelogenous leukemia, BCR-ABL1 positive
XenograftIn vitro
Human
Peripheral blood
Normal
XenograftIn vitro
Human
Peripheral blood
XenograftIn vitro
Human
Peripheral blood
Childhood acute megakaryoblastic leukemia
XenograftIn vitro

COX

Human
Peripheral blood
Burkitt lymphoma
XenograftIn vitro
Human
Peripheral blood
Mantle cell lymphoma
XenograftIn vitro